Jennifer L. Peterson
Mayo Clinic
CancerInternal medicineRadiologyDistressSurgeryOncologyIntensive care medicineChemotherapyBiochemical recurrenceLymphomaProstatectomyProstate cancerRadiosurgeryPartial Breast IrradiationNuclear medicineIn patientSalvage radiationIncidence (epidemiology)Proportional hazards modelRadiation therapyBreast cancerMedicineCohortMeta-analysis
109Publications
12H-index
509Citations
Publications 112
Newest
Purpose/Objective(s) null Chimeric antigen receptor T-cell (CAR-T) therapy is utilized for patients with active non-Hodgkin lymphoma (NHL) refractory to recent treatments, sometimes even requiring bridging therapy during CAR-T manufacturing to maintain clinically stability for CAR-T infusion. We examined the metabolic kinetics of these patients’ lymphoma via F-18 fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) with the hypothesis that increasing metabolic disease par...
Source
#1A. Bush (Mayo Clinic)
#2Timothy D. Malouff (Mayo Clinic)H-Index: 7
Last. Bradford S. Hoppe (Mayo Clinic)H-Index: 30
view all 8 authors...
Purpose/Objective(s) null Nonagenarians often present with advanced stage malignancies and complex prior treatment courses. Additionally, the fragility of this patient population can significantly limit surgical or systemic treatment options. Palliative radiotherapy is often offered in these challenging cases, however there is scarce data to help guide clinicians on which select patients may be most appropriate for radiotherapy versus other comfort care measures. null null null Materials/Methods...
Source
PURPOSE/OBJECTIVE(S) Anti-CD19-directed chimeric antigen receptor T-cell therapy (CART) is a new treatment option for patients with relapsed and/or refractory non-Hodgkin lymphoma (NHL). We reviewed the outcomes of patients receiving CART and the potential role of bridging radiation therapy (bRT) in reducing local recurrences. MATERIALS/METHODS Following IRB approval, we retrospectively reviewed 120 patients with NHL who received CART between 2018 and 2020 at a multi-site single institution. Bas...
Source
#1Sikander AilawadhiH-Index: 23
#2Asher Chanan-Khan (Mayo Clinic)H-Index: 45
Last. John FriendH-Index: 4
view all 11 authors...
Source
#1Henry Ruiz-Garcia (Mayo Clinic)H-Index: 8
#2Jennifer L. Peterson (Mayo Clinic)H-Index: 12
Last. Daniel M. Trifiletti (Mayo Clinic)H-Index: 21
view all 9 authors...
Introduction Vestibular schwannomas (VS) are slow growing tumors. Although there are a wide variety of available treatment options, these tumors are often initially observed. We aimed to establish the presenting symptoms and outcomes of patients treated with initial observation at our institution. Methods The medical records of patients with radiographically diagnosed VS were reviewed from 1989 to 2018. Actuarial estimates of radiographic tumor control and freedom of local therapy were calculate...
Source
Source
#10Norbert Avril (University Hospitals of Cleveland)H-Index: 9
82 null Background: null null Patients ≥ 55 years of age with high-risk acute myeloid leukemia (AML) may benefit from an allogeneic hematopoietic stem cell transplantation (HSCT), which is often the only potentially curative therapy available. However, complete remission (CR) is usually a prerequisite for most centers to perform HSCT, as CR predicts an optimal outcome. Many older patients with relapsed/refractory (R/R) AML do not receive HSCT, as they do not achieve the required CR. Additionally...
#1Eric J. Lehrer (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 15
#2Arpan V. Prabhu (University of Arkansas for Medical Sciences)H-Index: 13
Last. Daniel M. Trifiletti (Mayo Clinic)H-Index: 21
view all 11 authors...
Stereotactic radiosurgery (SRS) involves the delivery of a highly conformal ablative dose of radiation to both benign and malignant targets. This has traditionally been accomplished in a single fraction; however, fractionated approaches involving five or fewer treatments have been delivered for larger lesions, as well as lesions in close proximity to radiosensitive structures. The clinical utilization of SRS has overwhelmingly involved photon-based sources via dedicated radiosurgery platforms (e...
Source
#1Aaron Bush (Mayo Clinic)
#2Laura A. Vallow (Mayo Clinic)H-Index: 16
Last. Jennifer L. Peterson (Mayo Clinic)H-Index: 12
view all 9 authors...
Abstract The Gamma Knife Icon (Elekta AB, Stockholm) is a cobalt-based stereotactic radiosurgery (SRS) unit to support the use of a thermoplastic mask in lieu of a rigid frame, using an onboard cone-beam CT (CBCT) and an intrafraction motion management system (IFMM). We retrospectively reviewed 124 patients treated with Gamma Knife SRS from January 2018 to December 2019 at our institution using a mask-based immobilization system. Patient and treatment characteristics were collected and summarize...
Source
#8Anne Marie Langlois (Université de Sherbrooke)H-Index: 2
OBJECTIVE Radiation-induced meningiomas (RIMs) are associated with aggressive clinical behavior. Stereotactic radiosurgery (SRS) is sometimes considered for selected RIMs. The authors investigated the effectiveness and safety of SRS for the management of RIMs. METHODS From 12 institutions participating in the International Radiosurgery Research Foundation, the authors pooled patients who had prior cranial irradiation and were subsequently clinically diagnosed with WHO grade I meningiomas that we...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.